![Kenneth Carter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Carter
Fondateur chez
Noble Life Sciences, Inc.
Profil
Kenneth C.
Carter is the founder.
Founded NexImmune, Inc. in 2011 as Chairman, President & Chief Executive Officer.
Founded Avalon Pharmaceuticals, Inc. in 1999 as President & Chief Executive Officer.
Founded Noble Life Sciences, Inc. in 2010 as Chairman.
Dr. Carter is also the founder of Noble BioVentures LLC,NeoDiagnostix, Inc. Current job at Iterion Therapeutics, Inc. as Director since 2011.
Current job at MdBio, Inc. as Director.
Current job at Maryland Health Care Product Development Corp.
as Director since 2007.
Current job at Biohealth Innovation, Inc. as Director.
Current job at Apollomics, Inc. (United States) as Independent Director since 2023.
Current job at Antidote Therapeutics, Inc. as Director since 2016.
Current job at Neuimmune, Inc. as Director.
Former job at Seneca Biopharma, Inc. as Executive Chairman in 2021.
Former job at Apollomics, Inc. as Independent Director from 2023 to 2025.
Former job at Human Genome Sciences, Inc. as Senior Scientist from 1993 to 1999.
Education from Abilene Christian University with an undergraduate degree.
Education from the University of Texas Medical Branch with a doctorate degree.
Postes actifs de Kenneth Carter
| Sociétés | Poste | Début |
|---|---|---|
MdBio, Inc.
 MdBio, Inc. Miscellaneous Commercial ServicesCommercial Services Non-profit bioscience networking and business development organization | Directeur/Membre du Conseil | - |
Noble Life Sciences, Inc.
 Noble Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides in vitro and in vivo preclinical drug development services | Fondateur | 01/01/2010 |
Biohealth Innovation, Inc.
 Biohealth Innovation, Inc. Financial ConglomeratesFinance Sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth | Directeur/Membre du Conseil | - |
Iterion Therapeutics, Inc.
 Iterion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceuticals services | Directeur/Membre du Conseil | 01/01/2011 |
Antidote Therapeutics, Inc.
 Antidote Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | 01/01/2016 |
Maryland Health Care Product Development Corp. | Directeur/Membre du Conseil | 01/01/2007 |
Neuimmune, Inc.
 Neuimmune, Inc. BiotechnologyHealth Technology Develops vaccines and biopharmaceuticals | Directeur/Membre du Conseil | - |
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Develops mono therapies and combination therapies of tumor-targeting and immuno-oncology agents | Directeur/Membre du Conseil | 30/03/2023 |
Anciens postes connus de Kenneth Carter
| Sociétés | Poste | Fin |
|---|---|---|
| APOLLOMICS, INC. | Directeur/Membre du Conseil | 03/09/2025 |
| ░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Kenneth Carter
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
53
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
NeoDiagnostix, Inc.
 NeoDiagnostix, Inc. Medical/Nursing ServicesHealth Services Develops molecular diagnostic and prognostic tests for the treatment of cancer | Health Services |
Iterion Therapeutics, Inc.
Iterion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceuticals services | Health Technology |
NexImmune, Inc.
 NexImmune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops T cell immunotherapies | Health Technology |
Noble Life Sciences, Inc.
Noble Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides in vitro and in vivo preclinical drug development services | Health Technology |
MdBio, Inc.
MdBio, Inc. Miscellaneous Commercial ServicesCommercial Services Non-profit bioscience networking and business development organization | Commercial Services |
Abilene Christian University
 Abilene Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalon Pharmaceuticals, Inc.
 Avalon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics products | Health Technology |
Seneca Biopharma, Inc.
 Seneca Biopharma, Inc. BiotechnologyHealth Technology Manufactures biotherapeutic products | Health Technology |
University of Texas Medical Branch
 University of Texas Medical Branch Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Maryland Health Care Product Development Corp. | |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth | Finance |
Noble BioVentures LLC
 Noble BioVentures LLC Investment ManagersFinance Noble BioVentures invests in companies located in the United States. The firm targets companies operating in the fields of technology and biomedical sectors. It provides financing for early stage capital requirements. | Finance |
Apollomics, Inc. (United States)
Apollomics, Inc. (United States) BiotechnologyHealth Technology Develops mono therapies and combination therapies of tumor-targeting and immuno-oncology agents | Health Technology |
Antidote Therapeutics, Inc.
Antidote Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Neuimmune, Inc.
Neuimmune, Inc. BiotechnologyHealth Technology Develops vaccines and biopharmaceuticals | Health Technology |
Apollomics, Inc.
 Apollomics, Inc. Financial ConglomeratesFinance Operates as a biotechnology company that focuses on development of novel medicines for cancer patients | Finance |
